| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP.
|
Proc Natl Acad Sci U S A
|
2008
|
3.98
|
|
2
|
An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling.
|
Mol Cell Neurosci
|
2009
|
2.28
|
|
3
|
Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins.
|
Biochem J
|
2010
|
1.94
|
|
4
|
IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein, specifically binds to and activates pancreas-type Na+/HCO3- cotransporter 1 (pNBC1).
|
Proc Natl Acad Sci U S A
|
2006
|
1.61
|
|
5
|
IRBIT coordinates epithelial fluid and HCO3- secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct.
|
J Clin Invest
|
2008
|
1.32
|
|
6
|
Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1.
|
Biochem J
|
2003
|
1.19
|
|
7
|
IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway.
|
J Clin Invest
|
2011
|
1.18
|
|
8
|
Distinct role of the N-terminal tail of the Na,K-ATPase catalytic subunit as a signal transducer.
|
J Biol Chem
|
2006
|
1.11
|
|
9
|
Irbit mediates synergy between ca(2+) and cAMP signaling pathways during epithelial transport in mice.
|
Gastroenterology
|
2013
|
1.10
|
|
10
|
A genome-wide screen of CREB occupancy identifies the RhoA inhibitors Par6C and Rnd3 as regulators of BDNF-induced synaptogenesis.
|
PLoS One
|
2013
|
1.01
|
|
11
|
Inositol 1,4,5-triphosphate receptor-binding protein released with inositol 1,4,5-triphosphate (IRBIT) associates with components of the mRNA 3' processing machinery in a phosphorylation-dependent manner and inhibits polyadenylation.
|
J Biol Chem
|
2009
|
0.89
|
|
12
|
UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan.
|
Cancer Sci
|
2013
|
0.86
|
|
13
|
Three Japanese cases of inflammatory bowel disease associated with left-sided colonic diverticulosis: its implication.
|
Inflamm Bowel Dis
|
2005
|
0.84
|
|
14
|
Phase II trial of cetuximab plus irinotecan for oxaliplatin- and irinotecan-based chemotherapy-refractory patients with advanced and/or metastatic colorectal cancer: evaluation of efficacy and safety based on KRAS mutation status (T-CORE0801).
|
Oncology
|
2014
|
0.81
|
|
15
|
[Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
|
Gan To Kagaku Ryoho
|
2007
|
0.80
|
|
16
|
Isolation of inositol 1,4,5-trisphosphate receptor-associating proteins and selective knockdown using RNA interference.
|
Methods Mol Biol
|
2010
|
0.75
|